Macoska et al showed synergistic interaction in bladder cancer cell lines treated with gossypol in combination with gemcitabine or carboplatin, resulting in an increase in apoptosis via the decreased expression of pro-survival Bcl-xl and Mcl-1 and increased expression of pro-apoptotic genes [34]. This evidence concerns the gene BCL2L1 and urinary bladder carcinoma.